TACROLIMUS IMPURITY F
UNII CJ99AS37NC

Substance Identification & Data

This profile provides standardized clinical and technical data for Tacrolimus Impurity F, uniquely identified by the FDA Unique Ingredient Identifier (UNII) CJ99AS37NC.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1393890-33-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

CJ99AS37NC

CAS Registry Number

1393890-33-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

TACROLIMUS IMPURITY F

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C44H69NO12

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

ZPKGWFOANXPORW-RCRFZRKUSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

155923087

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

O1C([C@]2(N(C(C(C([C@@H](C[C@@H]([C@@H]([C@H](C[C@H](C/C(=C/[C@H](C(C[C@@H]([C@H]([C@H]1\C(=C\[C@H]3C[C@H]([C@@H](CC3)O)OC)\C)C)O)=O)CC=C)/C)C)OC)O)OC)C)=O)=O)=O)CCCC2)[H])=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tacrolimus Impurity F. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

TACROLIMUS COMPOUND I

TACROLIMUS COMPOUND I [EP IMPURITY]

TACROLIMUS IMPURITY F

TACROLIMUS MONOHYDRATE IMPURITY F [EP IMPURITY]

TACROLIMUS RING-OPENING IMPURITY

Systematic Nomenclature

(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26AS)-5,15-DIHYDROXY-3-((1E)-1-((1R,3R,4R)-4-HYDROXY-3-METHOXYCYCLOHEXYL)PROP-1-EN-2-YL)-14,16-DIMETHOXY-4,10,12,18-TETRAMETHYL-8-(PROP-2-EN-1-YL)-3,4,5,6,11,12,13,14,15,16,17,18,24,25,26,26A-HEXADECAHYDRO-7H-PYRIDO(2,1-C)(1,4)OXAAZACYCLOTRICOSINE-1,7,19,20,21(8H,23H)-PENTONE

SYS

3H-PYRIDO(2,1-C)(1,4)OXAAZACYCLOTRICOSINE-1,7,19,20,21(4H,8H,23H)-PENTONE, 5,6,11,12,13,14,15,16,17,18,24,25,26,26A-TETRADECAHYDRO-5,15-DIHYDROXY-3-((1E)-2-((1R,3R,4R)-4-HYDROXY-3-METHOXYCYCLOHEXYL)-1-METHYLETHENYL)-14,16-DIMETHOXY-4,10,12,18-TETRAMETHYL-8-(2-PROPEN-1-YL)-, (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,26AS)-

SYS

External Clinical & Regulatory Resources

Previous UNIICJ981S4H3T

Next UNIICJ9B9U6JJQ